While some of these compounds show potential for supporting muscle maintenance and recovery, most are still considered experimental and unregulated, making them extremely risky to use without medical guidance
In research, GH secretagogues are usually grouped into two major categories: GHRH analogs, which activate the growth hormonereleasing hormone receptor Ghrelin/GHSR agonists, which activate the growth hormone secretagogue receptor Both pathways can increase GH-axis activity, but they do so through different upstream signals
contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Post-marketing surveillance through the FDA Adverse Event Reporting System (FAERS) and international pharmacovigilance databases continues to monitor for rare or delayed adverse effects
Research suggests that continued metformin use and structured exercise programs can help reduce weight regain
Rare Allergic Reactions Though rare, some individuals may be sensitive to the sulfur content in glutathione
